The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. ARS Pharmaceuticals Inc shares valued at $615,075 were sold by Shawver Laura on Apr 07 ’25. At $12.30 per share, Shawver Laura sold 50,002 shares. The insider’s holdings dropped to 210,346 shares worth approximately $2.78 million following the completion of this transaction.
Also, Shawver Laura purchased 50,002 shares, netting a total of over 615,051 in proceeds.
Before that, Karas Eric had sold 10,000 shares from its account. In a trade valued at $140,000, the Chief Commercial Officer traded ARS Pharmaceuticals Inc shares for $14.00 each. Upon closing the transaction, the insider’s holdings decreased to 10,000 shares, worth approximately $0.1 million.
As published in their initiating research note from Scotiabank on March 07, 2025, ARS Pharmaceuticals Inc [SPRY] has been a Sector outperform and the price target has been revised to $30. Analysts at Oppenheimer started covering the stock with ‘”an Outperform”‘ outlook in a report released in early February. As of August 20, 2024, Cantor Fitzgerald has initiated its “an Overweight” rating for SPRY. Earlier on August 13, 2024, Raymond James upgraded its rating. Their new recommendation was “a Strong buy” for SPRY stock which previously was a “an Outperform”.
Analyzing SPRY Stock Performance
During the last five days, there has been a drop of approximately -1.19%. Over the course of the year, ARS Pharmaceuticals Inc shares have jumped approximately 25.50%. Shares of the company reached a 52-week high of $15.19 on 01/27/25 and a 52-week low of $10.00 on 03/04/25. A 50-day SMA is recorded $12.01, while a 200-day SMA reached $12.58.
Support And Resistance Levels for ARS Pharmaceuticals Inc (SPRY)
According to the 24-hour chart, there is a support level at 12.81, which, if violated, would cause prices to drop to 12.37. In the upper region, resistance lies at 13.67. The next price resistance is at 14.09. RSI (Relative Strength Index) is 56.80 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.12, which suggests the price will decrease in the coming days. Percent R is at 27.46%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
